日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers

一种协同双药疗法专门针对p53缺陷型结直肠癌和胰腺癌中发生的DNA修复失调。

Mohammed M Alruwaili ,Justin Zonneville ,Maricris N Naranjo ,Hannah Serio ,Thomas Melendy ,Robert M Straubinger ,Bryan Gillard ,Barbara A Foster ,Priyanka Rajan ,Kristopher Attwood ,Sarah Chatley ,Renuka Iyer ,Christos Fountzilas ,Andrei V Bakin

WHSC1/NSD2 regulates immune infiltration in prostate cancer

WHSC1/NSD2 调节前列腺癌的免疫浸润

Muzamil Y Want, Takemasa Tsuji, Prashant K Singh, James L Thorne, Junko Matsuzaki, Ellen Karasik, Bryan Gillard, Eduardo Cortes Gomez, Richard C Koya, Amit Lugade, Kunle Odunsi, Sebastiano Battaglia

LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer

LSD1 在介导前列腺癌中维生素 D 信号的表观遗传破坏中的双重功能

Sebastiano Battaglia, Ellen Karasik, Bryan Gillard, Jennifer Williams, Trisha Winchester, Michael T Moser, Dominic J Smiraglia, Barbara A Foster

The essential role of methylthioadenosine phosphorylase in prostate cancer

甲硫腺苷磷酸化酶在前列腺癌中的重要作用

Gaia Bistulfi, Hayley C Affronti, Barbara A Foster, Ellen Karasik, Bryan Gillard, Carl Morrison, James Mohler, James G Phillips, Dominic J Smiraglia

A genome-wide RNAi screen identifies FOXO4 as a metastasis-suppressor through counteracting PI3K/AKT signal pathway in prostate cancer

全基因组 RNAi 筛选确定 FOXO4 是一种通过抵消前列腺癌中的 PI3K/AKT 信号通路来抑制转移的抑制剂

Bing Su, Lingqiu Gao, Catherine Baranowski, Bryan Gillard, Jianmin Wang, Ryan Ransom, Hyun-Kyung Ko, Irwin H Gelman